CNTB: Connect Biopharma Holdings Company Short-Term Debt
Connect Biopharma minimizes capital expenditures by outsourcing drug manufacturing and testing to external contractors. Laboratories in China and the US support its scientific potential, while production at CDMO sites eliminates technical downtime. Monitoring of current debt shows that the indicator level is 0.00, while Zuheng Xu adapts business processes following the revision of asset rights.
Metric breakdowns and analytics for Connect Biopharma Holdings (CNTB)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital Connect Biopharma|CNTB - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Connect Pharma|CNTB - Company Total Debt|Debt to Book Capitalization Ratio Connect Biopharma Holdings Limited|CNTB - Company Long-Term Liabilities|Company Current Liabilities Connect Biopharma|Quick Liquidity connectbiopharm.com
- net income and valuation multiples indicators:
Initial company analysis:CNTB - connectbiopharm.com
For Connect Biopharma (CNTB), the current volume of short-term loans reflects financial stability within an isolated clinical trial cycle, where liquidity depends directly on successes in inflammatory disease therapies. This metric captures the dynamics between the issuance and repayment of obligations, while decreasing line volatility confirms payment stability, which minimizes risks but limits the potential for outsized returns typical of high-risk assets.
Competitor analysis
ARGX - Company Short-Term Debt|Company Short-Term Loans and Borrowings BNTX (BioNTech Inc.)|Abivax (ABVX) - Company Short-Term Debt|Company Current Liabilities ADMA Corp|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com|Company Current Liabilities KNSA (Kiniksa)|GRFS (Grifols SA) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ADPT (Adaptive Biotechnologies Corp)|Short-Term Debt Volume Celldex Corp (CLDX)|AUPH - Company Short-Term Debt|biocryst.com (BCRX) - Company Current Liabilities|Vera Therapeutics (VERA) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|Company Current Liabilities PHVS|Company Short-Term Debts abcellera.com|Company Short-Term Debt Tourmaline Bio, Inc. (TRML)|precigen.com - Company Short-Term Indebtedness|Company Short-Term Debts PHAR (Pharming Group)|Nektar Therapeutics Inc (NKTR) - Short-Term Debt|Upstream Bio Corp - Company Short-Term Debts|Zenas Corp (ZBIO) - Company Current Liabilities|Immunome, Inc. (IMNM) - Company Short-Term Debt|Short-Term Debt gossamerbio.com (GOSS)|Company Short-Term Debt KalVista Pharmaceuticals, Inc.|Company Short-Term Indebtedness SEPN (Septerna, Inc.)|Company Short-Term Debt Pieris Pharmaceuticals Inc (PVLA)|Savara Pharma - Company Short-Term Indebtedness|Company Short-Term Debts RIGL (Rigel Pharmaceuticals)|anaptysbio.com (ANAB) - Short-Term Debt|Astria Therapeutics, Inc. - Company Short-Term Debts|enGene Holdings Inc (ENGN) - Company Current Liabilities|RAPT (RAPT Therapeutics) - Company Current Liabilities|JBIO: Amount of Current Liabilities|Company Current Liabilities ACRS|KYTX: Company Short-Term Loans and Borrowings|Company Short-Term Debts TLSA|Company Short-Term Debt CABA (Cabaletta Bio Inc.)|Company Short-Term Debts VTYX (Ventyx Bio)|Short-Term Debt Volume Theratechnologies, Inc (THTX)|AVTX - Company Short-Term Debt|Short-Term Debt eledon.com|Agenus Inc. (AGEN) - Company Short-Term Debt|Current Liabilities CLYM (Climb Bio Inc.)|ZURA (Zura Bio) - Company Short-Term Debts|ATYR: Company Short-Term Loans and Borrowings|Company Short-Term Debts ADAG|Company Short-Term Debts ikenaoncology.com (IMA)|Company Short-Term Debt Shattuck Labs STTK|Company Short-Term Loans and Borrowings EQ|IMUX - Company Short-Term Debt|Atara Biotherapeutics (ATRA) - Company Current Liabilities|IFRX: Company Short-Term Debts|x4pharma.com (XFOR) - Company Short-Term Debts|ACET (Adicet Bio Inc.) - Company Short-Term Debts|Company Current Liabilities Celularity Corp (CELU)|Company Short-Term Debt INmune Bio Corp (INMB)|Barinthus Biotherapeutics Corp - Company Short-Term Indebtedness|Kezar Life Sciences - Company Current Liabilities|Amount of Current Liabilities SABS (sabbiotherapeutics.com)|Akari Therapeutics Plc - Company Short-Term Debts|ENLV: Company Short-Term Debt|q32bio.com (QTTB) - Company Short-Term Debt|Current Liabilities GOVX (GeoVax Corp)|EDSA (Edesa Biotech, Inc.) - Company Short-Term Debts|IBIO: Company Short-Term Loans and Borrowings|Company Short-Term Debts CARM|Company Short-Term Debts XTL Biopharmaceuticals Ltd (XTLB)|Company Short-Term Debt Bolt Biotherapeutics, Inc. BOLT|Company Short-Term Loans and Borrowings HCWB|APVO - Company Short-Term Debt|aimimmuno.com (AIM) - Company Current Liabilities|ADTX: Company Short-Term Debts|GRI Bio Inc (GRI) - Company Short-Term Debts|Company Current Liabilities XRTX|HIND: Company Short-Term Loans and Borrowings|Company Short-Term Debts REVB|Short-Term Debt Volume indaptusrx.com|Company Short-Term Debt Scinai Immunotherapeutics Ltd. SCNI|CALI - Company Current Liabilities|AFMD - Company Short-Term Debt|Allakos Inc. (ALLK) - Company Current Liabilities|HOOK (hookipapharma.com) - Company Current Liabilities|IGM Biosciences (IGMS) - Company Short-Term Debts|Company Short-Term Debt iTeos Therapeutics, Inc.|Company Short-Term Indebtedness OCEA (Ocean Biomedical Inc)|Company Short-Term Debts TCBP|THRD - Short-Term Debt